Works matching DE "SANOFI-Synthelabo Inc."
Results: 4
A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout: Was its Withdrawal from the Market in the Best Interest of Patients?
- Published in:
- Drug Safety, 2008, v. 31, n. 8, p. 643, doi. 10.2165/00002018-200831080-00002
- By:
- Publication type:
- Article
FDA evaluating oxaliplatin for advanced colorectal cancer treatment.
- Published in:
- 2002
- By:
- Publication type:
- journal article
PRODUCT UPDATE.
- Published in:
- Oncology Nursing Forum, 2002, v. 29, n. 9, p. 1351, doi. 10.1188/02.ONF.1351-1352
- By:
- Publication type:
- Article
The Socio-Political Economy of Pharmaceutical Mergers: A Case Study of Sanofi and Aventis.
- Published in:
- 2006
- By:
- Publication type:
- Case Study